Cambiar Investors LLC Novartis Ag Transaction History
Cambiar Investors LLC
- $2.18 Billion
- Q2 2025
A detailed history of Cambiar Investors LLC transactions in Novartis Ag stock. As of the latest transaction made, Cambiar Investors LLC holds 2,303 shares of NVS stock, worth $274,770. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,303
Previous 4,113
44.01%
Holding current value
$274,770
Previous $458,000
39.3%
% of portfolio
0.01%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding NVS
# of Institutions
1,552Shares Held
142MCall Options Held
1.64MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA10.6MShares$1.27 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.24 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.08 Billion0.26% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$850 Million0.35% of portfolio
-
Morgan Stanley New York, NY7.06MShares$842 Million0.06% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $257B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...